Zydus Wellness Limited
ZYDUSWELL · Pharma · NSE
₹497
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for ZYDUSWELL yet. Reason: Data Limited.
Updated 1h ago
YieldIQ Score
—
Piotroski F-Score
6/9
Economic Moat
None
Confidence
48%
ROE
6.1%
Debt/Equity
0.03
WACC
12.8%
Market Cap
₹15,804 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
6.8%
Return on capital employed
EV / EBITDA
38.4×
Enterprise multiple
Debt / EBITDA
0.4×
Leverage vs earnings
Interest Coverage
31.9×
EBIT covers interest
Current Ratio
1.48×
Short-term liquidity
Asset Turnover
—
Revenue per ₹ of assets
Revenue CAGR (3Y)
11.2%
3-year revenue growth
Revenue CAGR (5Y)
9.9%
5-year revenue growth
Ratio Trends
ZYDUSWELL · last 4 annual periods
ROE
6.1%
ROCE
6.8%
Operating Margin
—
Debt / Equity
0.03×
PE
31.8×
EV / EBITDA
30.5×
Historical Financials
ZYDUSWELL · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1988 Cr | ₹2243 Cr | ₹2315 Cr | ₹2691 Cr | ₹3940 Cr | +18.6% |
| EBITDA | ₹355 Cr | ₹332 Cr | ₹308 Cr | ₹399 Cr | ₹475 Cr | +7.6% |
| EBIT | ₹332 Cr | ₹307 Cr | ₹284 Cr | — | — | -3.8% |
| PAT | ₹309 Cr | ₹310 Cr | ₹267 Cr | ₹347 Cr | ₹197 Cr | -10.6% |
| EPS (diluted) | ₹48.54 | ₹48.78 | ₹41.94 | — | — | -3.6% |
| CFO | ₹237 Cr | ₹91.7 Cr | ₹246 Cr | ₹380 Cr | ₹226 Cr | -1.1% |
| CapEx | ₹-75.4 Cr | ₹-45.0 Cr | ₹-28.5 Cr | ₹-66.3 Cr | ₹-102 Cr | — |
| FCF | ₹161 Cr | ₹46.7 Cr | ₹218 Cr | ₹314 Cr | ₹125 Cr | -6.2% |
| Total Assets | ₹5692 Cr | ₹5833 Cr | ₹6148 Cr | ₹6442 Cr | ₹10.3K Cr | +16.0% |
| Total Debt | ₹387 Cr | ₹297 Cr | ₹329 Cr | ₹188 Cr | ₹3203 Cr | +69.6% |
| Shareholders' Equity | ₹4844 Cr | ₹5123 Cr | ₹5358 Cr | ₹5672 Cr | ₹5826 Cr | +4.7% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ZYDUSWELL vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 BIKAJI Bikaji Foods International Limited | -66.5% | 40 | Above Fair Value | 16.1% | — |
 LTFOODS LT Foods Limited | +80.0% | 40 | Below Fair Value | 13.8% | — |
 CCL CCL Products (India) Limited | -31.5% | 35 | Above Fair Value | 16.6% | 35.7× |
 AVANTIFEED Avanti Feeds Limited | -20.0% | 44 | Near Fair Value | 18.4% | — |
 GODREJAGRO GODREJAGRO | — | — | Pending | 122.9% | 21.8× |
Click a ticker to view its fair-value analysis.
Dividend History
9 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹5.20/sh
Last payout
2025-07-11
₹1.20
Peak payout
₹1.60
Trailing yield
0.24%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of ZYDUSWELL →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ZYDUSWELL →
Compare
Head-to-head with peers
Compare ZYDUSWELL side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ZYDUSWELLNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.